Clinical Features of COVID-19-Related Liver Functional Abnormality

Clinical Gastroenterology and Hepatology

Volumn 18, Issue 7, 2020, Pages 1561-1566

  Fan, Zhenyu ^a   Chen, Liping ^a   Li, Jun ^a   Cheng, Xin ^a   Yang, Jingmao ^a   Tian, Cheng ^a   Zhang, Yajun ^a   Huang, Shaoping ^a   Liu, Zhanju ^b   Cheng, Jilin ^a  

^a FUDAN UNIVERSITY   (China)

^b TENTH PEOPLE S HOSPITAL OF TONGJI UNIVERSITY   (China)

Author keywords

ALP; Antiviral Drug; Liver Injury; Prognosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; C REACTIVE PROTEIN; DARUNAVIR; GAMMA GLUTAMYLTRANSFERASE; LOPINAVIR PLUS RITONAVIR; PROCALCITONIN; UMIFENOVIR; ANTIVIRUS AGENT; ENZYME; LOPINAVIR; RITONAVIR;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CORONAVIRUS DISEASE 2019; FEMALE; FEVER; HOSPITAL ADMISSION; HUMAN; LENGTH OF STAY; LIVER FUNCTION; LIVER FUNCTION TEST; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SEX DIFFERENCE; BETACORONAVIRUS; BLOOD; BLOOD ANALYSIS; CHINA; COMPLICATION; CORONAVIRUS INFECTION; HOSPITAL; ISOLATION AND PURIFICATION; LIVER DISEASE; MIDDLE AGED; PANDEMIC; PATHOLOGY; PREVALENCE; VIRUS PNEUMONIA;

ADULT; ANTIVIRAL AGENTS; BETACORONAVIRUS; BILIRUBIN; BLOOD CHEMICAL ANALYSIS; CHINA; CORONAVIRUS INFECTIONS; ENZYMES; FEMALE; HOSPITALS; HUMANS; LIVER DISEASES; LIVER FUNCTION TESTS; LOPINAVIR; MALE; MIDDLE AGED; PANDEMICS; PNEUMONIA, VIRAL; PREVALENCE; RETROSPECTIVE STUDIES; RITONAVIR;

EID: 85084384641     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2020.04.002     Document Type: Article

References (25)

1. Zhu, N., Zhang, D., Wang, W., et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382 (2020), 727–733.
2. Huang, C., Wang, Y., Li, X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395 (2020), 497–506.
3. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2[J]. Nat Microbiol 5 (2020), 536–544.
4. World Health Organization. WHO Director-General's remarks at the media briefing on 2019-nCoV on 11 February 2020. Available at: https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020 Accessed February 20, 2020.
5. Li, Q., Guan, X., Wu, P., et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 382 (2020), 1199–1207.
6. Chinese Center for Disease Control and Prevention. Available at: http://2019ncov.chinacdc.cn/2019-nCoV/global.html Accessed March 20, 2020.
7. Wang, D., Hu, B., Hu, C., et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 323 (2020), 1061–1069.
8. Chen, N., Zhou, M., Dong, X., et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395 (2020), 507–513.
9. Xiaoqiang Chai LH, Yan Zhang. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. bioRxiv 2020. Available at: https://doi.org/10.1101/2020.02.03.931766. Accessed February 20, 2020.
10. Zhou, P., Yang, X.L., Wang, X.G., et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579 (2020), 270–273.
11. Xu, Z., Shi, L., Wang, Y., et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 8 (2020), 420–422.
12. China National Health Commission. Diagnosis and treatment scheme of new coronavirus infected pneumonia. 2020. Available at: http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2.shtml?security_session_verify=ee9c2d723cdbcd6a4b2c0d881dcfcb2c Accessed February 20, 2020.
13. Yang, Qingbin Lu, Mingjin Liu, et al. Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China. medRxiv 2020. Available at: https://doi.org/10.1101/2020.02.06.20020974. Accessed February 20, 2020.
14. Novel Coronavirus Pneumonia Emergency Response Epidemiology T. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi 41 (2020), 145–151.
15. Bai, Y., Yao, L., Wei, T., et al. Presumed asymptomatic carrier transmission of COVID-19. JAMA 323 (2020), 1406–1407.
16. Holshue, M.L., DeBolt, C., Lindquist, S., et al. First case of 2019 novel coronavirus in the United States. N Engl J Med 382 (2020), 929–939.
17. Guo, Y., Korteweg, C., McNutt, M.A., Gu, J., Pathogenetic mechanisms of severe acute respiratory syndrome. Virus Res 133 (2008), 4–12.
18. Shi, X., Gong, E., Gao, D., et al. Severe acute respiratory syndrome associated coronavirus is detected in intestinal tissues of fatal cases. Am J Gastroenterol 100 (2005), 169–176.
19. Farcas, G.A., Poutanen, S.M., Mazzulli, T., et al. Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus. J Infect Dis 191 (2005), 193–197.
20. Lee, N., Hui, D., Wu, A., et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 348 (2003), 1986–1994.
21. Assiri, A., Al-Tawfiq, J.A., Al-Rabeeah, A.A., et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis 13 (2013), 752–761.
22. Yancheva, N., Tzonev, R., A case of late presentation of darunavir-related cholestatic hepatitis. Int J STD AIDS 30 (2019), 620–622.
23. Jaeschke, H., McGill, M.R., Ramachandran, A., Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity. Drug Metab Rev 44 (2012), 88–106.
24. Sherman, K.E., Shire, N.J., Cernohous, P., et al. Liver injury and changes in hepatitis C Virus (HCV) RNA load associated with protease inhibitor-based antiretroviral therapy for treatment-naive HCV-HIV-coinfected patients: lopinavir-ritonavir versus nelfinavir. Clin Infect Dis 41 (2005), 1186–1195.
25. Chen, J., Ling, Y., Xi, X., et al. Efficacies of lopinavir/ritonavir and arbidol in the treatment of novel coronavirus pneumonia. Chin J Infect Dis 38 (2020), 86–89.